Calidi Biotherapeutics, Inc. Share Price
AMEX: CLDI | Micro CapCalidi Biotherapeutics, Inc. Stock Performance
Open $1.74 | Prev. Close $1.76 | Circuit Range N/A |
Day Range $1.61 - $1.75 | Year Range $0.09 - $6.00 | Volume 1,609 |
Average Traded $1.65 |
Calidi Biotherapeutics, Inc. Share Price Today
As of 10 August 2026, Calidi Biotherapeutics, Inc.'s share price is $1.61. The stock opened at $1.74, compared to its previous close of $1.76. During today's trading session, Calidi Biotherapeutics, Inc.'s share price traded between $1.61 and $1.75, with an average price of $1.68. Over the past 52 weeks, the stock has recorded a high of $6.00 and a low of $0.09. In terms of performance, Calidi Biotherapeutics, Inc.'s share price has risen by 107.58% over the last six months and is up 0.31% on a year-on-year basis.
Calidi Biotherapeutics, Inc. Share Price Chart
Calidi Biotherapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $6947.73 | PE Ratio (TTM) -0.27 | Dividend Yield N/A |
EPS (TTM) $-5.95 | Revenue (TTM) N/A | Return On Equity (TTM) -533.73% |
Profit Margin N/A | Debt to Equity 1.05 | Quarterly Earnings Growth YoY -1.88% |
Calidi Biotherapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Calidi Biotherapeutics, Inc. Annual Profit & Loss
All figures in USD
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Calidi Biotherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.55 | $1.62 | +1,641.94% |
Jul 2026 | $0.16 | $0.09 | -44.97% |
Jun 2026 | $0.18 | $0.17 | -7.65% |
May 2026 | $0.22 | $0.18 | -20.78% |
Apr 2026 | $0.24 | $0.23 | -3.75% |
Mar 2026 | $0.78 | $0.24 | -69.15% |
Feb 2026 | $0.97 | $0.78 | -21.81% |
Jan 2026 | $1.22 | $0.99 | -14.59% |
Dec 2025 | $1.47 | $1.17 | -23.86% |
Nov 2025 | $1.57 | $1.53 | +0.66% |
Oct 2025 | $1.55 | $1.52 | -0.65% |
Sep 2025 | $1.70 | $1.53 | -4.97% |
CLDI Share Price FAQs
What is Calidi Biotherapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Calidi Biotherapeutics, Inc. stock?
What is CLDI's market capitalisation today?
What is CLDI's net income for the last quarter?
What is the 5 year returns of CLDI?
What is the high & low stock price of CLDI today?
Can I buy CLDI shares in India?